Global DNA methylation, DNMT1, and MBD2 in patients with systemic lupus erythematosus

Lupus

Volumn 20, Issue 2, 2011, Pages 131-136

  Liu, C C ^a   Ou, T T ^b   Wu, C C ^b   Li, R N ^c   Lin, Y C ^a   Lin, C H ^b   Tsai, W C ^b   Liu, H W ^b   Yen, J H ^a,b,c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

DNMT1; MBD2; methylation; systemic lupus erythematosus

Indexed keywords

DNA METHYLTRANSFERASE 1; MESSENGER RNA; METHYL CPG BINDING PROTEIN 2;

ADULT; ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA-BINDING PROTEINS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RNA, MESSENGER;

EID: 79953308274     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310381517     Document Type: Article

References (35)

1. Sestak AL, Nath SK, Sawalha AH, Harley JB. Current status of lupus genetics. Arthritis Res Ther 2007; 9: 210.
2. Jonsen A, Bengtsson AA, Nived O, Truedsson L, Sturfelt G. Gene-environment interactions in the aetiology of systemic lupus erythematosus. Autoimmunity 2007; 40: 613-617.
3. Ng HH, Bird A. DNA methylation and chromatin modification. Curr Opin Genet Dev 1999; 9: 158-163. (Pubitemid 29158549)
4. Surani MA. Imprinting and the initiation of gene silencing in the germ line. Cell 1998; 93: 309-312. (Pubitemid 28232072)
5. Nakao M. Epigenetics: interaction of DNA methylation and chromatin. Gene 2001; 278: 25-31. (Pubitemid 33055776)
6. Richardson B, Yung R. Role of DNA methylation in the regulation of cell function. J Lab Clin Med 1999; 134: 333-340. (Pubitemid 29490152)
7. Detich N, Theberge J, Szyf M. Promoter-specific activation and demethylation by MBD2/demethylase. J Biol Chem 2002; 277: 35791-35794.
8. Nishida N, Nagasaka T, Nishimura T, Ikai I, Boland CR, Goel A. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Hepatology 2008; 47: 908-918. (Pubitemid 351449682)
9. Robertson KD. DNA methylation and human disease. Nat Rev Genet 2005; 6: 597-610. (Pubitemid 41044297)
10. Wilson AS, Power BE, Molloy PL. DNA hypomethylation and human diseases. Biochim Biophys Acta 2007; 1775: 138-162. (Pubitemid 44881198)
11. Richardson B. DNA methylation and autoimmune disease. Clin Immunol 2003; 109: 72-79. (Pubitemid 37324744)
12. Richardson B. Primer: epigenetics of autoimmunity. Nat Clin Pract Rheumatol 2007; 3: 521-527. (Pubitemid 47351397)
13. Balada E, Ordi-Ros J, Vilardell-Tarres M. DNA methylation and systemic lupus erythematosus. Ann N Y Acad Sci 2007; 1108: 127-136. (Pubitemid 47528726)
14. Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1990; 33: 1665-1673.
15. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277. (Pubitemid 13221242)
16. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
17. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
18. Jamaluddin MS, Yang X, Wang H. Hyperhomocysteinemia, DNA methylation and vascular disease. Clin Chem Lab Med 2007; 45: 1660-1666.
19. Castro R, Rivera I, Struys EA, et al. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem 2003; 49: 1292-1296. (Pubitemid 36900615)
20. Balada E, Ordi-Ros J, Serrano-Acedo S, Martinez-Lostao L, Rosa-Leyva M, Vilardell-Tarres M. Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus. Immunology 2008; 124: 339-347.
21. Snell C, Krypuy M, Wong EM, Loughrey MB, Dobrovic A. BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype. Breast Cancer Res 2008; 10: R12.
22. Cheng X, Blumenthal RM. Mammalian DNA methyltransferases: a structural perspective. Structure 2008; 16: 341-350. (Pubitemid 351324115)
23. Deng C, Kaplan MJ, Yang J, et al. Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum 2001; 44: 397-407.
24. Slack A, Cervoni N, Pinard M, Szyf M. Feedback regulation of DNA methyltransferase gene expression by methylation. Eur J Biochem 1999; 264: 191-199. (Pubitemid 29385882)
25. Fan G, Hutnick L. Methyl-CpG binding proteins in the nervous system. Cell Res 2005; 15: 255-261. (Pubitemid 41642881)
26. Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006; 31: 89-97. (Pubitemid 43221841)
27. Bhattacharya SK, Ramchandani S, Cervoni N, Szyf M. A mammalian protein with specific demethylase activity for mCpG DNA. Nature 1999; 397: 579-583.
28. Ng HH, Zhang Y, Hendrich B, et al. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat Genet 1999; 23: 58-61. (Pubitemid 29418788)
29. Quddus J, Johnson KJ, Gavalchin J, et al. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest 1993; 92: 38-53. (Pubitemid 23208979)
30. Hahn BH, Tsao BP. Pathogenesis of Systemic Lupus Erythematosus. In: Firestein GS, Budd RC, Harris Jr ED, McInnes IB, Ruddy S, Sergent S (eds), Kelley's Textbook of Rheumatology. Philadelphia, PA: WB Saunders Company; 2008. 1233-1262.
31. Januchowski R, Prokop J, Jagodzinski PP. Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus. J Appl Genet 2004; 45: 237-248. (Pubitemid 38834576)
32. Deng C, Lu Q, Zhang Z, et al. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum 2003; 48: 746-756. (Pubitemid 36302012)
33. Cornacchia E, Golbus J, Maybaum J, Strahler J, Hanash S, Richardson B. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J Immunol 1988; 140: 2197-2200. (Pubitemid 18098475)
34. Lee BH, Yegnasubramanian S, Lin X, Nelson WG. Procainamide is a specific inhibitor of DNA methyltransferase 1. J Biol Chem 2005; 280: 40749-40756. (Pubitemid 41780565)
35. Nyce J. Drug-induced DNA hypermethylation and drug resistance in human tumors. Cancer Res 1989; 49: 5829-5836. (Pubitemid 19274132)